Kraematon Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Sell |
951
-4
| -0.4% | -$1.78K | 0.4% | 61 |
|
|
2025
Q1 | $463K | Sell |
955
-82
| -8% | -$39.8K | 0.47% | 56 |
|
|
2024
Q4 | $418K | Sell |
1,037
-75
| -7% | -$30.2K | 0.41% | 58 |
|
|
2024
Q3 | $517K | Buy |
1,112
+81
| +8% | +$37.7K | 0.51% | 51 |
|
|
2024
Q2 | $483K | Hold |
1,031
| – | – | 0.49% | 54 |
|
|
2024
Q1 | $431K | Buy |
+1,031
| New | +$431K | 0.43% | 57 |
|
|
2023
Q1 | – | Sell |
-327
| Closed | -$94.4K | – | 249 |
|
|
2022
Q4 | $94.4K | Buy |
+327
| New | +$94.4K | 0.1% | 107 |
|